comparemela.com

Latest Breaking News On - Neoantigen therapy - Page 1 : comparemela.com

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational.

Moderna, Inc : Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates

Moderna, Inc : Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates

Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55Reports full-year revenues of $6.8 billion, GAAP net loss of $(4.7) billion and GAAP diluted EPS of $(12.33); loss primarily driven by mostly non-cash charges of $3.7 billion related to resizing and a tax valu.

Moderna Provides Business and Pipeline Updates at 42nd Annual J P Morgan Healthcare Conference

Moderna Provides Business and Pipeline Updates at 42nd Annual J P Morgan Healthcare Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.